[HTML][HTML] Biomarkers in chronic kidney disease: a review

RG Fassett, SK Venuthurupalli, GC Gobe… - Kidney international, 2011 - Elsevier
Chronic kidney disease (CKD) is a major public health problem. The classification of CKD by
KDOQI and KDIGO and the routine eGFR reporting have resulted in increased identification …

Chronic kidney disease: biomarker diagnosis to therapeutic targets

YN Wang, SX Ma, YY Chen, L Chen, BL Liu, QQ Liu… - Clinica Chimica …, 2019 - Elsevier
Chronic kidney disease (CKD), characterized as renal dysfunction, is recognized as a major
public health problem with high morbidity and mortality worldwide. Unfortunately, there are …

Metabolomics approaches for the diagnosis and understanding of kidney diseases

H Abbiss, GL Maker, RD Trengove - Metabolites, 2019 - mdpi.com
Diseases of the kidney are difficult to diagnose and treat. This review summarises the
definition, cause, epidemiology and treatment of some of these diseases including chronic …

Personalized medicine in chronic kidney disease by detection of monogenic mutations

DM Connaughton, F Hildebrandt - Nephrology Dialysis …, 2020 - academic.oup.com
A large fraction of early-onset chronic kidney disease (CKD) is known to be monogenic in
origin. To date,∼ 450 monogenic (synonymous with single-gene disorders) genes, if …

[HTML][HTML] Therapeutic insights in chronic kidney disease progression

A Shabaka, C Cases-Corona… - Frontiers in …, 2021 - frontiersin.org
Chronic kidney disease (CKD) has been recognized as a leading public health problem
worldwide. Through its effect on cardiovascular risk and end-stage kidney disease, CKD …

Genetic and epigenetic factors influencing chronic kidney disease

LJ Smyth, S Duffy, AP Maxwell… - American Journal of …, 2014 - journals.physiology.org
Chronic kidney disease (CKD) has become a serious public health problem because of its
associated morbidity, premature mortality, and attendant healthcare costs. The rising …